GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Laboratory Corp of America Holdings (NYSE:LH) » Definitions » 3-Year Dividend Growth Rate

Laboratory of America Holdings (Laboratory of America Holdings) 3-Year Dividend Growth Rate

: 0.00% (As of Dec. 2023)
View and export this data going back to 1991. Start your Free Trial

Laboratory of America Holdings's Dividends per Share for the three months ended in Dec. 2023 was $0.72.

The historical rank and industry rank for Laboratory of America Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Laboratory of America Holdings was 74.70% per year. The lowest was -33.30% per year. And the median was 20.70% per year.

LH's 3-Year Dividend Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 10.1
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

During the past 12 months, Laboratory of America Holdings's average Dividends Per Share Growth Rate was 33.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Laboratory of America Holdings's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.22. As of today, Laboratory of America Holdings's Dividend Yield % is 1.46%.

Good Sign:

Laboratory Corp of America Holdings stock dividend yield is close to 2-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Diagnostics & Research subindustry, Laboratory of America Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratory of America Holdings 3-Year Dividend Growth Rate Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Laboratory of America Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Laboratory of America Holdings's 3-Year Dividend Growth Rate falls into.



Laboratory of America Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Laboratory of America Holdings  (NYSE:LH) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Laboratory of America Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.72/ 3.3
=0.22

During the past 13 years, the highest Dividend Payout Ratio of Laboratory of America Holdings was 0.23. The lowest was 0.16. And the median was 0.19.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Laboratory of America Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7202024-02-262024-02-272024-03-13Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-11-072023-11-082023-12-12Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-08-072023-08-082023-09-08Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-05-172023-05-182023-06-08Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Laboratory of America Holdings's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=2.88/199.45
=1.44 %

Current Share Price is $199.45.
Laboratory of America Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.88.

During the past 13 years, the highest Dividend Yield of Laboratory of America Holdings was 1.56%. The lowest was 0.32%. And the median was 1.31%.

Good Sign:

Laboratory Corp of America Holdings stock dividend yield is close to 2-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratory of America Holdings 3-Year Dividend Growth Rate Related Terms>


Laboratory of America Holdings (Laboratory of America Holdings) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Executives
Peter J Wilkinson officer: SVP, Chief Accounting Officer C/O PHARMACEUTICAL PRODUCT DEVELOPMENT, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Kerrii B Anderson director WENDY'S INTERNATIONAL, INC, 4288 WEST DUBLIN-GRANVILLE RD., DUBLIN OH 43017
Van Der Vaart Sandra D officer: SVP, Global General Counsel 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Paul Rothman director 6 MEADOW ROAD, BALTIMORE MD 21212
Paul R Kirchgraber officer: CEO, Covance Drug Development 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark S Schroeder officer: EVP, President-Diagnostics Lab 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Megan D. Bailey officer: EVP, Chief Strategy Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Jonathan P. Divincenzo officer: EVP, Pres, Central Labs & Intl 940 WINTER STREET, PERKINELMER, INC. LEGAL DEPARTMENT, WALTHAM MA 02451
Anita Z Graham officer: EVP, CHRO C/O THE ADT CORPORATION, 1501 YAMATO ROAD, BOCA RATON FL 33431
Thomas Pike officer: Pres & CEO Clinical Business C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601
Kirsten Marie Kliphouse director 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Glenn A Eisenberg officer: Chief Financial Officer, EVP P O BOX 1017, CHARLOTTE NC 28201-1017
Brian J Caveney officer: SVP, Chief Medical Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
R Sanders Williams director DUKE UNIVERSITY SCHOOL OF MEDICINE, TRENT DRIVE, DURHAM NC 27706
Amy B. Summy officer: EVP, Chief Marketing Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215